these data illustrate that in a sizeable fraction of patients 35 years of age or younger treated with adjuvant doxorubicin-containing therapy , ovarian function remained intact and subsequent pregnancy did not affect the disease-free or overall survival of the patients .
C0013089
doxorubicin
C0032961
pregnancy